154 related articles for article (PubMed ID: 4659015)
1. [Clinical trial of immunotherapy for cancer].
Adler A; Stein JA; Maor M
Harefuah; 1972 Dec; 83(12):513-7. PubMed ID: 4659015
[No Abstract] [Full Text] [Related]
2. [Role of immunotherapy in the combined treatment of lung cancer].
Trapeznikov NN; Gorodilova VV; Babakova SV; Kadagidze ZG; Trakhtenberg AKh
Vopr Onkol; 1982; 28(2):51-6. PubMed ID: 6278769
[No Abstract] [Full Text] [Related]
3. [Immunotherapy of carcinoma of the lung].
Sega E; Mineo TC; Rea SR; Sega FM; Ricci C
Recenti Prog Med; 1978 Mar; 64(3):293-309. PubMed ID: 351751
[No Abstract] [Full Text] [Related]
4. Low doses of chemotherapy to inhibit suppressor T cells.
Berd D
Prog Clin Biol Res; 1989; 288():449-58. PubMed ID: 2566177
[No Abstract] [Full Text] [Related]
5. Correlation of immune reactivity and clinical status in cancer.
Chretien PB; Catalona WJ; Twomey PL; Sample WF
Ann Clin Lab Sci; 1974; 4(5):331-8. PubMed ID: 4851196
[No Abstract] [Full Text] [Related]
6. [Current status of immunotherapy of malignant tumors].
Flad HD; Betzler M; Herfarth C
Chirurg; 1979 Jan; 50(1):11-5. PubMed ID: 367730
[No Abstract] [Full Text] [Related]
7. [Immunotherapy of cancer with BCG].
Yamamura Y; Azuma I
Nihon Rinsho; 1974 Mar; 32(3):542-53. PubMed ID: 4603604
[No Abstract] [Full Text] [Related]
8. Active immunotherapy with ultraviolet B-irradiated autologous whole melanoma cells plus DETOX in patients with metastatic melanoma.
Eton O; Kharkevitch DD; Gianan MA; Ross MI; Itoh K; Pride MW; Donawho C; Buzaid AC; Mansfield PF; Lee JE; Legha SS; Plager C; Papadopoulos NE; Bedikian AY; Benjamin RS; Balch CM
Clin Cancer Res; 1998 Mar; 4(3):619-27. PubMed ID: 9533529
[TBL] [Abstract][Full Text] [Related]
9. Immunotherapy of malignancy in humans. Current status.
Holmes EC; Eilber FR; Morton DL
JAMA; 1975 Jun; 232(10):1052-5. PubMed ID: 236402
[TBL] [Abstract][Full Text] [Related]
10. Neuraminidase immunotherapy of tumors in man.
Rosato FE; Brown AS; Miller EE; Rosato EF; Mullis WF; Johnson J; Moskovitz A
Surg Gynecol Obstet; 1974 Nov; 139(5):675-82. PubMed ID: 4428323
[No Abstract] [Full Text] [Related]
11. Introduction: Immunotherapy of cancer in man, a reality.
Klein E
Natl Cancer Inst Monogr; 1973 Dec; 39():139-61. PubMed ID: 4206961
[No Abstract] [Full Text] [Related]
12. Immunotherapy of patients with cancer.
Smith GV; Morse PA; Deraps GD; Raju S; Hardy JD
Surgery; 1973 Jul; 74(1):59-68. PubMed ID: 4715883
[No Abstract] [Full Text] [Related]
13. Active immunotherapy with B.C.G. for melanoma.
Thompson RB
Panminerva Med; 1975; 17(5-6):189-92. PubMed ID: 1161318
[No Abstract] [Full Text] [Related]
14. Polyvalent melanoma cell vaccine induces delayed-type hypersensitivity and in vitro cellular immune response.
Barth A; Hoon DS; Foshag LJ; Nizze JA; Famatiga E; Okun E; Morton DL
Cancer Res; 1994 Jul; 54(13):3342-5. PubMed ID: 8012946
[TBL] [Abstract][Full Text] [Related]
15. [A review on mechanism of anti-tumor action of BCG (author's transl)].
Tokunaga T
Kekkaku; 1980 Aug; 55(8):351-7. PubMed ID: 6999202
[No Abstract] [Full Text] [Related]
16. Immunotherapy by intralesional injection of BCG cell walls or live BCG in bovine ocular squamous cell carcinoma: a preliminary report.
Klein WR; Ruitenberg EJ; Steerenberg PA; de Jong WH; Kruizinga W; Misdorp W; Bier J; Tiesjema RH; Kreeftenberg JG; Teppema JS; Rapp HJ
J Natl Cancer Inst; 1982 Nov; 69(5):1095-103. PubMed ID: 6957655
[TBL] [Abstract][Full Text] [Related]
17. [Cancer immunotherapy with BCG and its derivatives--clinical trials (author's transl)].
Ogura T
Kekkaku; 1980 Aug; 55(8):359-63. PubMed ID: 6999203
[No Abstract] [Full Text] [Related]
18. Primary inoculation tuberculosis after immunotherapy for malignant melanoma with BCG vaccine.
Caplan SE; Kauffman CL
J Am Acad Dermatol; 1996 Nov; 35(5 Pt 1):783-5. PubMed ID: 8912582
[No Abstract] [Full Text] [Related]
19. Distant cutaneous granulomas after bacille Calmette-Guérin immunotherapy for malignant melanoma: case for direct infection.
Moff SL; Corey GR; Gottfredsson M
Clin Infect Dis; 1999 Dec; 29(6):1569-70. PubMed ID: 10585816
[No Abstract] [Full Text] [Related]
20. Tissue microarray evaluation of Melanoma antigen E (MAGE) tumor-associated antigen expression: potential indications for specific immunotherapy and prognostic relevance in squamous cell lung carcinoma.
Bolli M; Kocher T; Adamina M; Guller U; Dalquen P; Haas P; Mirlacher M; Gambazzi F; Harder F; Heberer M; Sauter G; Spagnoli GC
Ann Surg; 2002 Dec; 236(6):785-93; discussion 793. PubMed ID: 12454517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]